TABLE 2.
Genetic variant* | Percentage of carriers with depressive symptomatology (%) | Percentage of noncarriers with depressive symptomatology (%) | P-value |
---|---|---|---|
LRRK2 G2019S mutation | 4.4 | 4.2 | 0.90 |
Any LRRK2 mutation | 5.7 | 4.7 | 0.65 |
Homozygous PRKN mutation | 9.3 | 10.2 | 0.82 |
Heterozygous PRKN | 6.6 | 9.8 | 0.37 |
APOE4 polymorphism | 20.0 | 26.5 | 0.18 |
Tests for association with genetic data were performed using only one individual per family (n = 537).